112 related articles for article (PubMed ID: 27151973)
1. Incidence, Characteristics, and Implications of Seizures in Patients With Glioblastoma.
Shin JY; Kizilbash SH; Robinson S; Uhm JH; Jatoi A
Am J Hosp Palliat Care; 2017 Aug; 34(7):650-653. PubMed ID: 27151973
[TBL] [Abstract][Full Text] [Related]
2. Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with Seizure.
Flanigan PM; Jahangiri A; Kuang R; Truong A; Choi S; Chou A; Rick JW; Chang SM; Molinaro AM; McDermott MW; Berger MS; Aghi MK
Neurosurgery; 2017 Nov; 81(5):824-833. PubMed ID: 28541497
[TBL] [Abstract][Full Text] [Related]
3. Epileptic features and survival in glioblastomas presenting with seizures.
Toledo M; Sarria-Estrada S; Quintana M; Maldonado X; Martinez-Ricarte F; Rodon J; Auger C; Aizpurua M; Salas-Puig J; Santamarina E; Martinez-Saez E
Epilepsy Res; 2017 Feb; 130():1-6. PubMed ID: 28073027
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of epilepsy in glioblastomas.
Toledo M; Sarria-Estrada S; Quintana M; Maldonado X; Martinez-Ricarte F; Rodon J; Auger C; Salas-Puig J; Santamarina E; Martinez-Saez E
Clin Neurol Neurosurg; 2015 Dec; 139():166-71. PubMed ID: 26489387
[TBL] [Abstract][Full Text] [Related]
5. Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation.
Rahman R; Catalano PJ; Reardon DA; Norden AD; Wen PY; Lee EQ; Nayak L; Beroukhim R; Dunn IF; Golby AJ; Johnson MD; Chiocca EA; Claus EB; Alexander BM; Arvold ND
J Neurooncol; 2015 Aug; 124(1):137-46. PubMed ID: 26033544
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for glioblastoma therapy associated complications.
Ening G; Osterheld F; Capper D; Schmieder K; Brenke C
Clin Neurol Neurosurg; 2015 Jul; 134():55-9. PubMed ID: 25942630
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic anticonvulsants in patients with primary glioblastoma.
Wali AR; Rennert RC; Wang SG; Chen CC
J Neurooncol; 2017 Nov; 135(2):229-235. PubMed ID: 28755321
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of seizure in patients with glioblastoma multiforme.
Ozbek N; Cakir S; Gursel B; Meydan D
Neurol India; 2004 Mar; 52(1):76-8. PubMed ID: 15069244
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma: clinical characteristics, prognostic factors and survival in 492 patients.
Stark AM; van de Bergh J; Hedderich J; Mehdorn HM; Nabavi A
Clin Neurol Neurosurg; 2012 Sep; 114(7):840-5. PubMed ID: 22377333
[TBL] [Abstract][Full Text] [Related]
10. Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article.
Chaichana KL; Parker SL; Olivi A; Quiñones-Hinojosa A
J Neurosurg; 2009 Aug; 111(2):282-92. PubMed ID: 19344222
[TBL] [Abstract][Full Text] [Related]
11. Preoperative thrombocytosis predicts poor survival in patients with glioblastoma.
Brockmann MA; Giese A; Mueller K; Kaba FJ; Lohr F; Weiss C; Gottschalk S; Nolte I; Leppert J; Tuettenberg J; Groden C
Neuro Oncol; 2007 Jul; 9(3):335-42. PubMed ID: 17504931
[TBL] [Abstract][Full Text] [Related]
12. Post-operative seizure control in patients with glioblastoma.
Hani U; Haider MA; Bakhshi SK; Shamim MS
J Pak Med Assoc; 2021 Jun; 71(6):1698-1700. PubMed ID: 34111103
[TBL] [Abstract][Full Text] [Related]
13. Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.
Kim YH; Kim T; Joo JD; Han JH; Kim YJ; Kim IA; Yun CH; Kim CY
Cancer; 2015 Sep; 121(17):2926-32. PubMed ID: 25975354
[TBL] [Abstract][Full Text] [Related]
14. The predictive potential of hyponatremia for glioblastoma patient survival.
Mrowczynski OD; Bourcier AJ; Liao J; Langan ST; Specht CS; Rizk EB
J Neurooncol; 2018 May; 138(1):99-104. PubMed ID: 29372493
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of patients with multifocal glioblastoma: a case-control study.
Patil CG; Yi A; Elramsisy A; Hu J; Mukherjee D; Irvin DK; Yu JS; Bannykh SI; Black KL; Nuño M
J Neurosurg; 2012 Oct; 117(4):705-11. PubMed ID: 22920963
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
[TBL] [Abstract][Full Text] [Related]
17. Perioperative seizure incidence and risk factors in 223 pediatric brain tumor patients without prior seizures.
Hardesty DA; Sanborn MR; Parker WE; Storm PB
J Neurosurg Pediatr; 2011 Jun; 7(6):609-15. PubMed ID: 21631197
[TBL] [Abstract][Full Text] [Related]
18. Seizures as presenting symptom in patients with glioblastoma.
Dührsen L; Sauvigny T; Ricklefs FL; Mende KC; Schaper M; Matschke J; Goebell E; Westphal M; Martens T
Epilepsia; 2019 Jan; 60(1):149-154. PubMed ID: 30536819
[TBL] [Abstract][Full Text] [Related]
19. The Last 10 Days of Patients With Glioblastoma: Assessment of Clinical Signs and Symptoms as well as Treatment.
Thier K; Calabek B; Tinchon A; Grisold W; Oberndorfer S
Am J Hosp Palliat Care; 2016 Dec; 33(10):985-988. PubMed ID: 26472939
[TBL] [Abstract][Full Text] [Related]
20. Incidence and prognostic significance of non-enhancing cortical signal abnormality in glioblastoma.
Lasocki A; Gaillard F; Tacey M; Drummond K; Stuckey S
J Med Imaging Radiat Oncol; 2016 Feb; 60(1):66-73. PubMed ID: 26597591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
